GENE ONLINE|News &
Opinion
Blog

ADCs
BIO Asia-Taiwan 2024 BIO Asia-Taiwan
BIO Asia–Taiwan 2024 Set to Showcase Global Biotech Industry Talent on July 24th
2024-07-03
Trending JPMJP Morgan 2024
JPM 2024: Biotech Companies Mapping Out Their Future, and a New Round of M&A Spree Begins
2024-01-09
Partnerships ADCsCancer
Merck Joins Forces with Daiichi Sankyo in $5.5 Billion Deal to Develop Cancer Drugs
2023-10-22
China Antibody
Sanofi Bets $2.5 billion on Adagene to Make Antibodies Safer
2022-03-03
Asia-Pacific Cancer
Astellas, Seagen Cancer Drug Becomes First and Only Approved ADC For Advanced Urothelial Cancer in Japan
2021-09-28
Trials & Approvals Cancer
Seagen, Genmab’s Antibody Drug Conjugate Bags FDA Approval for Cervical Cancer
2021-09-22
Licensing
Seagen Licenses ADC Asset From a Chinese Player to Disrupt HER2 Market
2021-08-10
Trials & Approvals
Roche Aspires for Dominance in DLBCL Market, Unveils Pivotal Trial Data for Polivy
2021-08-09
Sparx Therapeutics to Build a Massive Manufacturing Plant in China for Multi-Specific Antibody Production
2021-07-10
BMS Initiates Global Partnership to Advance Eisai’s First ADC to Market
2021-06-20
Asia-Pacific
WuXi Biologics and WuXi STA Establish Joint Venture to Advance Bioconjugates
2021-05-17
In-Depth
Antibody Drug Conjugates: The Next Big Thing in Cancer Therapy?
2021-03-20
Trials & Approvals Bladder Cancer
Astellas Submits New Drug Application Targeting First ADC Approval for Metastatic Urothelial Cancer in Japan
2021-03-13
M&A iADC platform
Boehringer Ingelheim’s Newest Acquisition Reinforces its Focus on Immuno-Oncology
2020-12-14
Trials & Approvals
ASH2020: VelosBio’s ROR1 Targeted Therapy Shines in Safety Trial
2020-12-09
1 2
LATEST
Advancements in Alzheimer’s Disease Drug Innovation and Funding Programs in 2024
2024-07-04
FDA Greenlights Eli Lilly’s Groundbreaking Alzheimer’s Drug Kisunla for Early Symptomatic Treatment
2024-07-04
Novo Nordisk’s CLARION-CKD Trial Shut Down After Unsuccessful Results Causing Impairment Loss
2024-07-03
Tanvex BioPharma Secures Asia’s First FDA Approval for Filgrastim Biosimilar, Seizing a $403 Million Market
2024-07-03
Ginkgo Job Cuts Expected to Affect at Least 35% of Workforce, Eliminating Over 400 Jobs
2024-07-02
Eli Lilly and OpenAI Team Up to Combat Drug-Resistant Pathogens
2024-07-02
Nucleate Taiwan Bridging Academia and Industry in the Field of Synbio
2024-07-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top